Theresa Boyle, MD, PhD, discusses the current approach to biomarker testing in lung cancer.
Theresa Boyle, MD, PhD
Advertisement
Articles by Theresa Boyle, MD, PhD
Theresa Boyle, MD, PhD, discusses the role of concurrent molecular testing in lung cancer.
Advertisement
Latest Updated Articles
Dr. Boyle on the Role of Concurrent Molecular Testing in Lung CancerPublished: March 10th 2021 | Updated:
Dr. Boyle on Approaching Biomarker Testing in Lung CancerPublished: March 24th 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
The OncFive: Top Oncology Articles for the Week of 1/25
3
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
4
HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts
5